Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat for residual renal function in peritoneal dialysis patients
ChiCTR1900026597Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Chengdu Medical College
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of roxadustat in anaemia and end-stage kidney disease (ESKD) (2 arms), sponsored by The First Affiliated Hospital of Chengdu Medical College. Primary endpoint: Residual renal function. Started Nov 2019; status: recruiting.
02
Drugs
roxadustat
03
Conditions
anaemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR1900026597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026597.